Latest news with #ChemkartIndia
Business Standard
14-07-2025
- Business
- Business Standard
BSE SME Chemkart India crawls higher on debut, lists at slight premium
Shares of Chemkart India was trading at Rs 258 on the BSE, a premium of 4.03% compared with the issue price of Rs 248. The scrip was listed at Rs 250, a premium of 0.81% compared with the initial public offer (IPO) price. The stock is currently up 3.20% over its listing price. The counter hit a high of Rs 262 and a low of Rs 250. About 11.56 lakh shares of the company changed hands at the counter. Chemkart India's IPO was subscribed 5.56 times. The issue opened for bidding on 7 July 2025 and it closed on 9 July 2025. The price band of the IPO was set at Rs 236 to Rs 248 per share. The IPO comprised 32,29,200 equity shares, including a fresh issue of upto 26,00,000 equity shares and offer for sale (OFS) of upto 6,29,200 equity shares. The company intends to utilize the net proceeds to finance capital expenditures for setting up the manufacturing facility through investment in its wholly-owned subsidiary (WOS), Easy Raw Materials, repayment or prepayment of all or certain borrowings availed by the company and for general corporate purposes. Ahead of the Chemkart India on 4 July 2025, raised Rs 22.60 crore from anchor investors. The board has allotted 9.11 lakh shares at Rs 248 per share to 14 anchor investors. Chemkart India is a one-stop destination for various nutritional, health, and sports supplement products, primarily focused on food products that provide health benefits in addition to their nutritional value. This reflects its ability to cater to both the nutritional and health needs of end customers. The company is based in Mumbai and offers a diverse range of captivating nutritional supplements and components. It offers products across seven categories: amino acids, health supplements, herbal extracts, nucleotides, proteins, sports nutrition, and vitamins. As of 31 March 2025, the company had 40 employees. The company recorded revenue from operations of Rs 203.28 crore and net profit of Rs 24.26 crore for the period ended 31 March 2025.
Mint
14-07-2025
- Business
- Mint
Chemkart India shares list on a flat note at ₹250 on BSE SME. Details here
Chemkart India IPO listing: Shares of Chemkart India listed on a lacklustre note on the BSE SME platform on Monday, July 14. Chemkart India share price debuted at ₹ 250 per share as against the issue price of ₹ 248, a premium of just 0.81%. However, within minutes of listing, Chemkart India share price extended gains as it rose to the day's high of ₹ 257.90, recording a 4% rise over the initial public offering (IPO) price. The listing was largely in line with the grey market premium (GMP) trends. Chemkart India IPO GMP was ₹ 3, signalling a 1% listing pop for the company shares. Chemkart India IPO had witnessed a decent demand for its IPO during the bidding process, which opened on July 7 and closed on July 9. At the end of the subscription period, Chemkart India IPO was booked 5.91 times. The individual investor portion was booked 1.63 times, and the non-institutional investor (NII) portion was subscribed 5.64 times. The qualified institutional buyer (QIB) portion was booked the most at 13.69 times. Chemkart India IPO was a book-building offer of ₹ 80.08 crore. The issue was a combination of a fresh issue of ₹ 64.48 crore and an offer for sale of ₹ 15.60 crore. The company plans to use the funds raised for financing the expenditure towards setting up a manufacturing facility through investment in a wholly-owned subsidiary, repayment of certain borrowings availed by the company and for general corporate purposes. Smart Horizon Capital Advisors Private Limited was the book-running lead manager of the Chemkart India IPO, while Bigshare Services Pvt Ltd acted as the registrar for the issue. Chemkart India is a distributor of high-quality food and health ingredients. The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein.
&w=3840&q=100)
Business Standard
14-07-2025
- Business
- Business Standard
Chemkart India shares make flat D-Street debut, list at ₹250 on BSE
Chemkart India IPO listing today: Shares of food and health ingredients company Chemkart India made a positive debut on the BSE SME platform today, July 14, 2025, following the completion of its initial public offering (IPO). The stock listed at ₹250 per share, reflecting a premium of only ₹2 or 0.8 per cent over the issue price of ₹248. Chemkart India IPO listing was in-line with the grey market estimates. Ahead of the listing, the unlisted shares of Chemkart were trading at around ₹251, indicating a grey market premium (GMP) of ₹3 or around 1.2 per cent over the issue price, according to sources tracking unofficial market activity. Chemkart India IPO details Chemkart India IPO comprises a fresh issue of 2.6 million equity shares aggregating to ₹64.48 crore and an offer for sale (OFS) up to 0.63 million equity shares worth ₹15.6 crore. The public offering was available for subscription from Monday, July 7, to Wednesday, July 9, at a price band of ₹236 to ₹248 per share and a lot size of 600 shares. The public issue received a lacklustre demand from investors, getting oversubscribed by only 5.9 times by the end of the subscription period, showed the BSE data. The portion reserved for qualified institutional buyers (QIBs) was booked 13.69 times, followed by non-institutional investors quota at 5.64 times and retail investors portion was booked 1.63 times. Chemkart India will not receive any proceeds from the OFS. According to the RHP, the company proposes to utilise the proceeds from the fresh offering for the setting up of the manufacturing facility through investment in the wholly owned subsidiary, Easy Raw Materials, and to repay debt. The remaining funds will be used for general corporate purposes. About Chemkart India Incorporated in 2020, Mumbai-based Chemkart India provides nutritional, health and sports supplement products. It offers products across mainly seven product categories, including Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin. The company operates a facility for grinding, blending, and packaging services in Bhiwandi, Mumbai. Its product portfolio includes amino acid, health supplements, herbal extracts, nucleotide, protien, sports nutrition, and vitamins.
Mint
14-07-2025
- Business
- Mint
Chemkart India shares list on a flat note at ₹250 on BSE SME. Details here
Chemkart India IPO listing: Shares of Chemkart India listed on a lacklustre note on the BSE SME platform on Monday, July 14. Chemkart India share price debuted at ₹ 250 per share as against the issue price of ₹ 248, a premium of just 0.81%. However, within minutes of listing, Chemkart India share price extended gains as it rose to the day's high of ₹ 257.90, recording a 4% rise over the initial public offering (IPO) price. The listing was largely in line with the grey market premium (GMP) trends. Chemkart India IPO GMP was ₹ 3, signalling a 1% listing pop for the company shares. Chemkart India IPO had witnessed a decent demand for its IPO during the bidding process, which opened on July 7 and closed on July 9. At the end of the subscription period, Chemkart India IPO was booked 5.91 times. The individual investor portion was booked 1.63 times, and the non-institutional investor (NII) portion was subscribed 5.64 times. The qualified institutional buyer (QIB) portion was booked the most at 13.69 times. Chemkart India IPO was a book-building offer of ₹ 80.08 crore. The issue was a combination of a fresh issue of ₹ 64.48 crore and an offer for sale of ₹ 15.60 crore. The company plans to use the funds raised for financing the expenditure towards setting up a manufacturing facility through investment in a wholly-owned subsidiary, repayment of certain borrowings availed by the company and for general corporate purposes. Smart Horizon Capital Advisors Private Limited was the book-running lead manager of the Chemkart India IPO, while Bigshare Services Pvt Ltd acted as the registrar for the issue. Chemkart India is a distributor of high-quality food and health ingredients. The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
14-07-2025
- Business
- Time of India
Chemkart India shares to debut. GMP hints at flat listing
Synopsis Chemkart India is ready to list on the Bombay Stock Exchange SME platform. The initial public offering of Rupees eighty crore was successful. The IPO was priced at Rupees two hundred forty eight per share. Market sources indicate a modest grey market premium. The company distributes food and health ingredients. Chemkart plans expansion through its subsidiary.
